Structures and functions of human placental aromatase and steroid sulfatase, two key enzymes in estrogen biosynthesis

[Display omitted] •Aromatase and steroid sulfatase are two key enzymes for the biosynthesis of estrogen and androgen.•Both enzymes were purified to homogeneity from human placenta and studied.•Important findings on their structure–function relationships are reviewed in this article. Cytochrome P450...

Full description

Saved in:
Bibliographic Details
Published inSteroids Vol. 196; p. 109249
Main Author Ghosh, Debashis
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •Aromatase and steroid sulfatase are two key enzymes for the biosynthesis of estrogen and androgen.•Both enzymes were purified to homogeneity from human placenta and studied.•Important findings on their structure–function relationships are reviewed in this article. Cytochrome P450 aromatase (AROM) and steroid sulfatase (STS) are the two key enzymes for the biosynthesis of estrogens in human, and maintenance of the critical balance between androgens and estrogens. Human AROM, an integral membrane protein of the endoplasmic reticulum, is a member of the cytochrome P450 superfamily. It is the only enzyme to catalyze the conversion of androgens with non-aromatic A-rings to estrogens characterized by the aromatic A-ring. Human STS, also an integral membrane protein of the endoplasmic reticulum, is a Ca2+-dependent enzyme that catalyzes the hydrolysis of sulfate esters of estrone and dehydroepiandrosterone to the unconjugated steroids, the precursors of the most potent forms of estrogens and androgens, namely, 17β-estradiol, 16α,17β-estriol, testosterone and dihydrotestosterone. Expression of these steroidogenic enzymes locally within organs and tissues of the endocrine, reproductive, and central nervous systems is the key for maintaining high levels of the reproductive steroids. The enzymes have been drug targets for the prevention and treatment of diseases associated with steroid hormone excesses, especially in breast, endometrial and prostate malignancies. Both enzymes have been the subjects of vigorous research for the past six decades. In this article, we review the important findings on their structure–function relationships, specifically, the work that began with unravelling of the closely guarded secrets, namely, the 3-D structures, active sites, mechanisms of action, origins of substrate specificity and the basis of membrane integration. Remarkably, these studies were conducted on the enzymes purified in their pristine forms from human placenta, the discarded and their most abundant source. The purification, assay, crystallization, and structure determination methodologies are described. Also reviewed are their functional quaternary organizations, post-translational modifications and the advancements made in the structure-guided inhibitor design efforts. Outstanding questions that still remain open are summarized in closing.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0039-128X
1878-5867
1878-5867
DOI:10.1016/j.steroids.2023.109249